An α-synuclein knockdown peptide
Technical Support & Resources

Information provided in the product description is from published literature. Due to the nature of scientific experimentation, your results (e.g., selectivity and effective concentrations) or specific application for this product may differ. If you have questions about how this product fits your application, please contact our technical support staff.

Visit our FAQ

Contact Us

Toll Free Phone (USA and Canada Only): (888) 526-5351
Direct Phone: (734) 975-3888

Request Technical Support

Technical Support Request

To streamline the process attach the appropriate questionnaire to your inquiry.

Download IHC QuestionnaireDownload WB Questionnaire

View Our Privacy Statement for details on how we use and protect your data. In addition, this site is protected by hCaptcha and its Privacy Policy and Terms of Service apply.

Tat-βsyn-degron (trifluoroacetate salt)

Item No. 37442

Technical Information
Formal Name
L-tyrosylglycyl-L-arginyl-L-lysyl-L-lysyl-L-arginyl-L-arginyl-L-glutaminyl-L-arginyl-L-arginyl-L-arginyl-L-arginyl-L-threonyl-L-lysyl-L-serylglycyl-L-valyl-L-tyrosyl-L-leucyl-L-valylglycyl-L-arginyl-L-arginyl-L-arginyl-glycine
Molecular Formula
C132H237N59O31 • XCF3COOH
Formula Weight
Purity
≥95%
A solid
Peptide Sequence
H-YGRKKRRQRRRRTKSGVYLVGRRRG-OH
DMF: 50 mg/mlPBS (pH 7.2): 1 mg/ml
SMILES
O=C(NCC(N[C@@H](CCCNC(N)=N)C(N[C@@H](CCCCN[H])C(N[C@@H](CCCCN[H])C(N[C@@H](CCCNC(N)=N)C(N[C@@H](CCCNC(N)=N)C(N[C@@H](CCC(N)=O)C(N[C@@H](CCCNC(N)=N)C(N[C@@H](CCCNC(N)=N)C(N[C@@H](CCCNC(N)=N)C(N[C@@H](CCCNC(N)=N)C(N[C@]([C@H](O)C)([H])C(N[C@@H](CCCCN[H])C(N[C@@H](CO)C(NCC(N[C@@H](C(C)C)C(N[C@@H](CC1=CC=C(O)C=C1)C(N[C@H](C(N[C@@H](C(C)C)C(NCC(N[C@@H](CCCNC(N)=N)C(N[C@@H](CCCNC(N)=N)C(N[C@@H](CCCNC(N)=N)C(NCC(O)=O)=O)=O)=O)=O)=O)=O)CC(C)C)=O)=O)=O)=O)=O)=O)=O)=O)=O)=O)=O)=O)=O)=O)=O)=O)=O)[C@H](CC2=CC=C(O)C=C2)N[H].OC(C(F)(F)F)=O
InChi Code
InChI=1S/C132H237N59O31.C2HF3O2/c1-68(2)60-91(119(219)190-99(69(3)4)120(220)170-64-96(198)173-79(29-16-52-160-125(142)143)106(206)177-83(30-17-53-161-126(144)145)109(209)174-77(27-14-50-158-123(138)139)103(203)171-66-98(200)201)186-118(218)92(62-73-39-43-75(195)44-40-73)187-121(221)100(70(5)6)189-97(199)65-169-104(204)93(67-192)188-115(215)82(26-10-13-49-135)185-122(222)101(71(7)193)191-117(217)89(36-23-59-167-132(156)157)183-113(213)86(33-20-56-164-129(150)151)180-111(211)85(32-19-55-163-128(148)149)179-112(212)87(34-21-57-165-130(152)153)182-116(216)90(45-46-94(137)196)184-114(214)88(35-22-58-166-131(154)155)181-110(210)84(31-18-54-162-127(146)147)178-108(208)81(25-9-12-48-134)176-107(207)80(24-8-11-47-133)175-105(205)78(28-15-51-159-124(140)141)172-95(197)63-168-102(202)76(136)61-72-37-41-74(194)42-38-72;3-2(4,5)1(6)7/h37-44,68-71,76-93,99-101,192-195H,8-36,45-67,133-136H2,1-7H3,(H2,137,196)(H,168,202)(H,169,204)(H,170,220)(H,171,203)(H,172,197)(H,173,198)(H,174,209)(H,175,205)(H,176,207)(H,177,206)(H,178,208)(H,179,212)(H,180,211)(H,181,210)(H,182,216)(H,183,213)(H,184,214)(H,185,222)(H,186,218)(H,187,221)(H,188,215)(H,189,199)(H,190,219)(H,191,217)(H,200,201)(H4,138,139,158)(H4,140,141,159)(H4,142,143,160)(H4,144,145,161)(H4,146,147,162)(H4,148,149,163)(H4,150,151,164)(H4,152,153,165)(H4,154,155,166)(H4,156,157,167);(H,6,7)/t71-,76+,77+,78+,79+,80+,81+,82+,83+,84+,85+,86+,87+,88+,89+,90+,91+,92+,93+,99+,100+,101+;/m1./s1
InChi Key
DHTOAOOUFFOQJU-INJORSAQSA-N
Shipping & Storage Information
Storage
-20°C
Shipping
Room temperature in continental US; may vary elsewhere
Recommended Products

Certificates of Analysis & Batch Specific Data

Provide batch numbers separated by commas to download or request available product inserts, QC sheets, certificates of analysis, data packs, and GC-MS data.

    Add

    Add

    Add

    Add

    Product Description

    Tat-βsyn-degron is an α-synuclein knockdown peptide.1 It is composed of the HIV-1 Tat plasma membrane transduction domain, the α-synuclein binding domain βsyn which corresponds to amino acids 36-45 of β-synuclein, and the proteasomal targeting domain degron. Tat-βsyn-degron binds to recombinant α-synuclein in a peptide-protein binding assay and reduces α-synuclein levels in primary rat cortical neuron cultures, an effect that can be prevented by the proteasomal inhibitor MG132. In vivo, Tat-βsyn-degron (40 mg/kg) reduces brain α-synuclein levels in M38 transgenic mice that overexpress human A53T mutant α-synuclein. It also reduces phosphorylated α-synuclein levels in the substantia nigra and the pons, as well as neuroinflammation in a mouse model of spreading synucleinopathy induced by α-synuclein preformed fibrils. Tat-βsyn-degron (6 µmol/kg, i.p.) protects against dopaminergic neuron loss and rescues motor deficits in a mouse model of MPTP-induced Parkinson’s disease.

    WARNING This product is not for human or veterinary use.

    References & Product Citations
    Product Description References

    1. Jin, J.W., Fan, X., Del Cid-Pellitero, E., et alDevelopment of an α-synuclein knockdown peptide and evaluation of its efficacy in Parkinson’s disease models. Commun. Biol. 4(1), 232 (2021).